Patents by Inventor Stig I. Gustavsson

Stig I. Gustavsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4797472
    Abstract: Tripeptide derivatives, characterized by the general formula:R.sub.1 --X--D--Arg--A--Arg--NH--R.sub.2wherein R.sub.1 is hydrogen, .alpha.- or .beta.-naphtyl residue, lower alkyl residue which may be substituted with a carboxyl group, unsubstituted or substituted phenyl- or phenylalkyl residue. ##STR1## or a single bond with the proviso that when R.sub.1 is hydrogen then and only then X is a single bondA=Gly or SarR.sub.2 =an aromatic or heterocyclic residue which gives a compound R.sub.2 --NH.sub.2 by enzymatic hydrolysis, which can be determined quantitativelyor disalts and trisalts of inorganic or organic acids thereof, process for their preparation and method for determination of serine proteases, especially Factor X.sub.a,or components which can interact with serine proteases or zymogen forms thereof.
    Type: Grant
    Filed: March 19, 1987
    Date of Patent: January 10, 1989
    Assignee: KabiVitrum AB
    Inventors: Stig I. Gustavsson, Salo Arielly
  • Patent number: 4537896
    Abstract: New thrombin inhibiting N.sup..alpha. -arylsulfonyl-p-guanidinophenylalanine amides of the formula ##STR1## wherein Ar is a substituted aryl and R.sub.1 and R.sub.2 are an alkyl group having 1-5 carbon atoms or together with the amine nitrogen form an heterocyclic ring, in racemate form as well as in form of optical active antipodes, theirs pharmaceutically acceptable salts, methods for their preparation, pharmaceutical composition and diagnostical preparation containing these compounds, use of the compounds in treatments of thrombosis and methods of treatment of thrombosis as well as methods for determination of thrombin concentration in blood.
    Type: Grant
    Filed: June 14, 1983
    Date of Patent: August 27, 1985
    Assignee: KabiVitrum AB
    Inventors: Carl G. Claeson, Stig I. Gustavsson
  • Patent number: 4214049
    Abstract: Method for the quantitative determination of serine proteases which includes contacting the substance for which the determination is desired with a diagnostically active chromogenic substrate with good stability and high specificity to serine proteases having the formula: H--D--A.sub.1 --A.sub.2 --A.sub.3 --NH--R or salts thereof, wherein A.sub.1 is Gly, Ala, Val, Leu, Ile, Pip, Pro, or Aze; A.sub.2 is Gly, Ala, Val, Leu, Ile, Pip, Pro, Aze, or Phe; A.sub.3 is Arg, Lys, or Orn, and R is a chromophoric group.
    Type: Grant
    Filed: October 27, 1978
    Date of Patent: July 22, 1980
    Assignee: AB Kabi
    Inventors: Bo T. af Ekenstam, Leif E. Aurell, Karl G. Claeson, Birgitta G. Karlsson, Stig I. Gustavsson, Gun A. Olausson
  • Patent number: 4137225
    Abstract: Diagnostically active chromogenic substrate with good stability and high specificity to serine proteases having the formula: H-D-A.sub.1 -A.sub.2 -A.sub.3 -NH-R or salts thereof, wherein A.sub.1 is Gly, Ala, Val, Leu, Ile, Pip, Pro, or Aze; A.sub.2 is Gly, Ala, Val, Leu, Ile, Pip, Pro, Aze, or Phe; A.sub.3 is Arg, Lys, or Orn, and R is a chromophoric group.
    Type: Grant
    Filed: March 20, 1978
    Date of Patent: January 30, 1979
    Assignee: Ab Kabi
    Inventors: Bo T. Af Ekenstam, Leif E. Aurell, Karl G. Claeson, Birgitta G. Karlsson, Stig I. Gustavsson, Gun A. Olausson